Various studies have been conducted on postoperative surveillance and adjuvant chemotherapy for patients with stage III colon cancer. The effectiveness of different treatment options, including irinotecan fluorouracil plus leucovorin and capecitabine plus oxaliplatin, have been compared in randomized controlled trials. Age and defective mismatch repair have also been studied as factors affecting the efficacy of adjuvant therapy in colon cancer.